Optamont (Olopatadine)

Olopatadine, the active ingredient in Optamont, is a selective histamine H1‑receptor antagonist presented as an ophthalmic solution for ocular use. It relieves symptoms of allergic eye disease such as itching, redness and swelling, and is also employed in the management of allergic rhinitis in adults and children. The formulation is designed for topical instillation, providing rapid onset of action and a favorable safety profile in the eye. Optamont is marketed within the European Union and complies with regional regulatory standards for quality and efficacy.

GNH USA supplies Optamont as a licensed, GDP‑compliant pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olopatadine is used to treat allergic conditions of the eye and nose.

Allergic conjunctivitis: reduces ocular itching, redness, swelling and tearing. Seasonal allergic rhinitis: alleviates nasal itching, sneezing, congestion and watery discharge. Vernal keratoconjunctivitis: helps control chronic inflammation and photophobia.

Olopatadine may cause adverse reactions, which are generally mild to moderate in severity.

Common Side Effects: - Burning or stinging sensation in the eye - Itching or mild irritation - Transient blurred vision - Headache - Dry eye sensation - Taste disturbance (if nasal spray)

Serious or Rare Side Effects: - Corneal edema or ulceration - Severe allergic reaction including anaphylaxis - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Significant intraocular pressure rise

When using Optamont, consider the following precautions. - Pregnancy: use only if clearly needed and prescribed by a physician - Breastfeeding: caution, assess risk versus benefit - Children: safety not established for ages below 2 years - Contact lens wear: avoid during treatment to reduce irritation - Concurrent ocular surgery: postpone use until healing - Store at room temperature: keep in original container, protect from moisture and light

Olopatadine can interact with other medicines; review the following.

Major Interactions (Avoid): - Concurrent use of other topical antihistamines: may increase local irritation - Systemic MAO inhibitors: can potentiate antihistaminic effects - Other ocular decongestants: additive vasoconstrictive effect

Moderate Interactions (Monitor Closely): - Alcohol consumption: may enhance sedation if systemic antihistamine is used - CYP450 inhibitors (e.g., ketoconazole): may affect metabolism of oral formulations - Anticholinergic agents: may worsen dry eye symptoms